AstraZeneca PLC
Biotech Specialty Pharma
15 Stanhope Gate
London, W1K 1LN United Kingdom
phone: :+44 (0)20 7304 5000
fax: :+44 (0)20 7304 5151
Symbol AZN
Exchange NYSE
Founded 0
Employees
www.astrazeneca.com
Research Sector Biotech Specialty Pharma
Summary Description
Prescription pharmaceuticals.
Management
David Brennan, Chief Executive Officer; Jonathan Symonds, Chief Financial Officer; Tony Zook, Executive Vice-President, North America; Bruno Angelici, Executive Vice-President, Europe, Japan, Asia Pacific and ROW; Martin Nicklasson, Executive VicePresident, Global Marketing; David Smith, Executive Vice-President, Operations; Jan Lundberg, Executive Vice-President, Discovery Research; John Patterson, Executive Director, Development; Tony Bloxham, Executive Vice-President, Human Resources
Ownership
Financials Mkt Cap :79


* numbers in thousands

 
Keywords
cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, inflammation, infection

Comment | Printable Version | Mar. 13, 2007
If you work for AstraZeneca PLC and want to update this profile, click here


Description
AstraZeneca PLC, is a research-based pharmaceutical company primarily engaged in providing effective medicines to fight disease in important areas of medical need: cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, inflammation, and infection. The Company's operations are focused on prescription pharmaceuticals, and more than 97% of its sales are made in that sector.


2008-11-15-370